Drugs / BISEGLIPTIN
last change Jan 2011 re-read 3 minutes ago

BISEGLIPTIN

also known as KRP-104 · Bisegliptina · Bisegliptine

Small molecule targets DPP4 via inhibition

Developed for
type 2 diabetes mellitus
Investigated by
ActivX Biosciences, Inc. · Kyorin Pharmaceutical Co.,Ltd

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Filed US (FDA) — type 2 diabetes mellitus —

“当社が創製したDPP‐4阻害薬「KRP‐104(開発コード)」について、ActivX Biosciences,Inc.(杏林製薬(株)の子会社、カリフォルニア州、Chairman、President ; John W. Kozarich)と共に米国FDA に対しIND申請し” kyorin-pharm.co.jp ↗

Trials 2

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00995345 Oct 2009 → Jan 2011 type 2 diabetes mellitus ActivX Biosciences, Inc. Completed No outcome recorded
Phase 2 NCT00525330 Sep 2007 → Aug 2008 type 2 diabetes mellitus ActivX Biosciences, Inc. Completed Met primary

News releases announcing trial results or a regulatory action · 1

DateIssuerRelease
2008-08-20 Kyorin Pharmaceutical Co.,Ltd Results 糖尿病治療薬「KRP‐104」の海外での第2相臨床試験等の結果について kyorin-pharm.co.jp ↗
この度、各々の臨床試験が終了し、主要な評価項目において目標とする結果を得ることができました。

All press releases naming this drug 1 release

DateIssuerRelease

Evidence & citations 7 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as BISEGLIPTIN ChEMBL registry synonym — accepted as the source's own label CHEMBL4297624 ↗
Known as Bisegliptina ChEMBL registry synonym — accepted as the source's own label CHEMBL4297624 ↗
Known as Bisegliptine ChEMBL registry synonym — accepted as the source's own label CHEMBL4297624 ↗
Known as KRP-104 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00525330 ↗
1

NCT00995345 ↗

Action Inhibit “Dipeptidyl peptidase IV inhibitor” CHEMBL4297624 ↗
1

“KRP-104, a novel DPP-IV inhibitor” NCT00525330 ↗

Modality Small molecule — CHEMBL4297624 ↗
Target DPP4 “Dipeptidyl peptidase IV inhibitor” CHEMBL4297624 ↗